Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $402B |
| FY2017, ended Dec 31, 2017 | $489B |
| FY2018, ended Dec 31, 2018 | $503B |
| FY2019, ended Dec 31, 2019 | $552B |
| FY2020, ended Dec 31, 2020 | $533B |
| FY2021, ended Dec 31, 2021 | $662B |
| FY2022, ended Dec 31, 2022 | $676B |
| FY2023, ended Dec 31, 2023 | $771B |
| FY2024, ended Dec 31, 2024 | $978B |
| FY2025, ended Dec 31, 2025 | $1.08T |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $1.07T |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $215B |
| FY2017, ended Dec 31, 2017 | $240B |
| FY2018, ended Dec 31, 2018 | $248B |
| FY2019, ended Dec 31, 2019 | $255B |
| FY2020, ended Dec 31, 2020 | $246B |
| FY2021, ended Dec 31, 2021 | $276B |
| FY2022, ended Dec 31, 2022 | $302B |
| FY2023, ended Dec 31, 2023 | $364B |
| FY2024, ended Dec 31, 2024 | $371B |
| FY2025, ended Dec 31, 2025 | $371B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $385B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $24.1B | $19.7B |
| FY2017, ended Dec 31, 2017 | $44.9B | $34.0B |
| FY2018, ended Dec 31, 2018 | $4.02B | $22.9B |
| FY2019, ended Dec 31, 2019 | $81.4B | $22.7B |
| FY2020, ended Dec 31, 2020 | $42.5B | $26.8B |
| FY2021, ended Dec 31, 2021 | $89.9B | $26.2B |
| FY2022, ended Dec 31, 2022 | −$22.8B | $21.9B |
| FY2023, ended Dec 31, 2023 | $96.2B | $29.8B |
| FY2024, ended Dec 31, 2024 | $89.0B | $11.6B |
| FY2025, ended Dec 31, 2025 | $67.0B | $25.0B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $85.8B | $24.2B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $28.0B |
| FY2017, ended Dec 31, 2017 | $31.6B |
| FY2018, ended Dec 31, 2018 | $30.8B |
| FY2019, ended Dec 31, 2019 | $64.6B |
| FY2020, ended Dec 31, 2020 | $48.4B |
| FY2021, ended Dec 31, 2021 | $88.7B |
| FY2022, ended Dec 31, 2022 | $36.4B |
| FY2023, ended Dec 31, 2023 | $38.6B |
| FY2024, ended Dec 31, 2024 | $48.4B |
| FY2025, ended Dec 31, 2025 | $52.6B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $41.4B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
No figures for this period in the company’s filings.
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 13.2% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 2.47B |
| FY2017, ended Dec 31, 2017 | 2.47B |
| FY2018, ended Dec 31, 2018 | 2.46B |
| FY2019, ended Dec 31, 2019 | 2.44B |
| FY2020, ended Dec 31, 2020 | 2.30B |
| FY2021, ended Dec 31, 2021 | 2.21B |
| FY2022, ended Dec 31, 2022 | 2.19B |
| FY2023, ended Dec 31, 2023 | 2.16B |
| FY2024, ended Dec 31, 2024 | 2.16B |
| FY2025, ended Dec 31, 2025 | 2.16B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | 2.14B |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back |
|---|---|
| FY2016, ended Dec 31, 2016 | — |
| FY2017, ended Dec 31, 2017 | — |
| FY2018, ended Dec 31, 2018 | $1.35B |
| FY2019, ended Dec 31, 2019 | $4.85B |
| FY2020, ended Dec 31, 2020 | $24.7B |
| FY2021, ended Dec 31, 2021 | $27.1B |
| FY2022, ended Dec 31, 2022 | $7.85B |
| FY2023, ended Dec 31, 2023 | $9.17B |
| FY2024, ended Dec 31, 2024 | $2.92B |
| FY2025, ended Dec 31, 2025 | — |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | — |
Valuation
At current price- Market Cap
- $1.16T
- P/E
- 13.6×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 3.0×
- Price / Book
- 1.6×
- EV / EBITDA
- —. (Market cap + debt − cash) / EBITDA (TTM)
Growth
Trailing 12 months- Revenue (TTM)
- $385B
- Revenue Growth YoY
- 3.9%
- Revenue CAGR 3Y
- 7.1%
- Revenue CAGR 5Y
- 8.6%
- EPS Growth YoY
- —. Diluted EPS, TTM vs. TTM a year earlier
- Net Income Growth YoY
- 36.3%
Profitability
Trailing 12 months- Gross Margin
- —
- Operating Margin
- 15.0%
- Net Margin
- 22.3%
- FCF Margin
- 6.3%
- Return on Equity
- 12.1%
Earnings
Trailing 12 months- Net Income
- $85.8B
- EPS (diluted)
- —
- EBITDA
- $71.9B
- Operating Income
- $57.9B
Balance Sheet
As of Jun 30, 2026- Cash and cash equivalents
- $41.4B
- Total Debt
- —. Short- and long-term borrowings, excluding leases
- Net Cash
- —. Cash − total debt
- Total Assets
- $1.26T
- Total Liabilities
- $513B
- Shareholders' Equity
- $748B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $46.6B
- Capital Expenditure
- $22.4B
- Free Cash Flow
- $24.2B
Dividends and risk
Last 12 months- Dividend Yield
- 0.0%
- Dividend / Share
- $0.00
- Beta (5Y)
- 0.60
Every ratio is calculated from the company’s reported figures.